Clinical and bacteriologic efficacy of amoxycillin b.d. (45 mg/kg/day) Versus Amoxycillin t.d.s (40 mg/kg/day) in children with group A β-hemolytic streptococcal tonsillopharyngitis

Journal of Chemotherapy

Volumn 12, Issue 5, 2000, Pages 396-405

  Aguilar, A ^a   Tinoco, J C ^a   Macias, M ^a   Huicho, L ^a   Levy, J ^a   Trujillo, H ^a   Lopez, P ^a   Pereira, M ^a   Maqbool, S ^a   Bhutta, Z A ^a   Sacy, R A ^a   Deacon, S ^a  

^a F Icaza Bustamante Children's Hosp   (Ecuador)

Author keywords

Acute streptococcal tonsillopharyngitis; Amoxycillin; Group A streptococci; Twice daily formulation.

Indexed keywords

AMOXICILLIN;

ABDOMINAL PAIN; ACUTE DISEASE; ALLERGY; ANTIBACTERIAL ACTIVITY; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS; DIARRHEA; DRUG EFFICACY; DRUG FORMULATION; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GASTROENTERITIS; HUMAN; MALE; MULTICENTER STUDY; NERVOUSNESS; PHARYNGITIS; RANDOMIZED CONTROLLED TRIAL; RASH; SINGLE BLIND PROCEDURE; SOMNOLENCE; STREPTOCOCCUS GROUP A; TASTE DISORDER; TREATMENT OUTCOME; URTICARIA; VOMITING;

EID: 0033766529     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2000.12.5.396     Document Type: Article

References (30)

1. Bacterial and viral throat flora
2. Viral and bacterial organisms associated with acute pharyngitis in a school-aged population
3. Complications of streptococcal pharyngitis
4. Management of streptococcal pharyngitis reconsidered
5. Prevention of rheumatic fever: A statement for health professionals by the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association
6. The effect of penicillin therapy on the symptoms and signs of streptococcal pharyngitis
7. Streptococcal pharyngitis: Placebo-controlled double-blind evaluation of clinical response to penicillin therapy
8. Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis
9. Adverse and beneficial effects of immediate treatment of group A beta-hemolytic streptococcal pharyngitis with penicillin
10. Standardized symptomatic treatment versus penicillin as initial therapy for streptococcal pharyngitis
11. The effect of penicillin prophylaxis on streptococcal disease rates and the carrier state
12. Treatment of beta-hemolytic streptococcal infections in the home: Relative value of available methods
13. Observations in air force recruits of streptococcal diseases and their control with orally administered penicillin
14. Five versus ten days' treatment of group A streptococcal pharyngotonsillitis: A randomized controlled clinical trial with phenoxymethylpenicillin and cefadroxil
15. Five days vs ten days of penicillin therapy for streptococcal pharyngitis
16. Penicillin V for group A streptococcal pharyngotonsillitis: A randomized trial of seven vs ten days' therapy
17. Treatment of pharyngitis associated with group A streptococcus: Comparison of amoxicillin and potassium phenoxymethyl penicillin
18. Treatment of streptococcal pharyngitis with amoxicillin
19. Treatment of streptococcal pharyngitis with amoxicillin once a day
20. 6-Day amoxicillin versus 10-day penicillin V for group A betahaemolytic streptococcal acute tonsillitis in adults: A French multicentre, open-label, randomized study. The French Study Group Clamorange
21. Six-day amoxicillin vs. ten-day penicillin V therapy for group A streptococcal tonsillopharyngitis
22. Antibiotic prescribing practices and patient compliance in the community
23. Five versus ten-day treatment of streptococcal pharyngotonsillitis: A randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin
24. Effective short-course treatment of acute group A beta-haemolytic streptococcal tonsillopharyngitis. Ten days of penicillin V vs 5 days or 10 days of cefpodoxime therapy in children
25. A double-blind, randomized trial comparing the efficacy and safety of a 5-day course of cefotiam hexetil with that of a 10-day course of penicillin V in adult patients with pharyngitis caused by group A beta-haemolytic streptococci
26. Multicentre comparison of azithromycin versus erythromycin in the treatment of paediatric pharyngitis or tonsillitis caused by group A streptococci
27. Evaluation of the efficacy, safety and toleration of azithromycin vs. penicillin V in the treatment of acute streptococcal pharyngitis in children: Results of a multicenter, open comparative study. The Swiss Tonsillopharyngitis Study Group
28. Pharyngitis - Principles of judicious use of antimicrobial agents